LONDON, March 2 (Reuters) - Haleon, the world's biggest standalone consumer health business, on Thursday forecast 4-6% organic revenue growth in 2023. (Reporting by Natalie Grover and Maggie Fick in London Editing by David Goodman )
![Thomson Reuters](https://static.lse.co.uk/images/news-logos/thomson-reuters-news-logo.png)
Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses
FTSE 100 down 0.2%, FTSE 250 up 0.8%
*Read more